141 related articles for article (PubMed ID: 23682235)
1. The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy.
Kapoor S
Korean J Intern Med; 2013 May; 28(3):374-5. PubMed ID: 23682235
[No Abstract] [Full Text] [Related]
2. Effect of phosphodiesterase inhibitor on diabetic nephropathy.
Kang SW
Korean J Intern Med; 2012 Jun; 27(2):151-3. PubMed ID: 22707885
[No Abstract] [Full Text] [Related]
3. In reply.
Sun HK; Han SY
Korean J Intern Med; 2013 May; 28(3):375-6. PubMed ID: 23819195
[No Abstract] [Full Text] [Related]
4. Phosphodiesterase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney.
Sun HK; Lee YM; Han KH; Kim HS; Ahn SH; Han SY
Korean J Intern Med; 2012 Jun; 27(2):163-70. PubMed ID: 22707888
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effect of pentoxifylline in advanced chronic kidney disease.
Kao CC; Wu MS
J Formos Med Assoc; 2015 Jan; 114(1):94. PubMed ID: 24974130
[No Abstract] [Full Text] [Related]
6. Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
Wiggins KJ; Tiauw V; Zhang Y; Gilbert RE; Langham RG; Kelly DJ
Nephrology (Carlton); 2008 Dec; 13(8):721-9. PubMed ID: 18826488
[TBL] [Abstract][Full Text] [Related]
7. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
Navarro-González JF; Sánchez-Niño MD; Donate-Correa J; Martín-Núñez E; Ferri C; Pérez-Delgado N; Górriz JL; Martínez-Castelao A; Ortiz A; Mora-Fernández C
Diabetes Care; 2018 Aug; 41(8):1817-1820. PubMed ID: 29866645
[TBL] [Abstract][Full Text] [Related]
8. Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy.
Han KH; Han SY; Kim HS; Kang YS; Cha DR
Inflammation; 2010 Jun; 33(3):137-43. PubMed ID: 19921414
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney.
Sönmez MF; Dündar M
Ren Fail; 2016; 38(4):605-13. PubMed ID: 26905686
[TBL] [Abstract][Full Text] [Related]
10. Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Mehanna OM; El Askary A; Al-Shehri S; El-Esawy B
Arch Physiol Biochem; 2018 Dec; 124(5):424-429. PubMed ID: 29271249
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats.
DiPetrillo K; Gesek FA
Am J Nephrol; 2004; 24(3):352-9. PubMed ID: 15205554
[TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: renoprotective effects of pentoxifylline in the PREDIAN trial.
He T; Cooper ME
Nat Rev Nephrol; 2014 Oct; 10(10):547-8. PubMed ID: 25201141
[No Abstract] [Full Text] [Related]
13. The renoprotective potential of pentoxifylline in chronic kidney disease.
Lin SL; Chiang WC; Chen YM; Lai CF; Tsai TJ; Hsieh BS
J Chin Med Assoc; 2005 Mar; 68(3):99-105. PubMed ID: 15813241
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus.
Dávila-Esqueda ME; Vertiz-Hernández AA; Martínez-Morales F
Ren Fail; 2005; 27(1):115-22. PubMed ID: 15717644
[TBL] [Abstract][Full Text] [Related]
15. The effects of pentoxifylline on diabetic renal changes in streptozotocin-induced diabetes mellitus.
Gunduz Z; Canoz O; Per H; Dusunsel R; Poyrazoglu MH; Tez C; Saraymen R
Ren Fail; 2004 Nov; 26(6):597-605. PubMed ID: 15600249
[TBL] [Abstract][Full Text] [Related]
16. A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria.
Badri S; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi M
J Pharm Pharm Sci; 2011; 14(1):128-37. PubMed ID: 21501559
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats.
Arcaro CA; Assis RP; Zanon NM; Paula-Gomes S; Navegantes LCC; Kettelhut IC; Brunetti IL; Baviera AM
J Appl Physiol (1985); 2018 Mar; 124(3):704-716. PubMed ID: 29357512
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of pentoxifylline on reproductive parameters in diabetic male mice.
Feyli SA; Ghanbari A; Keshtmand Z
Andrologia; 2017 Feb; 49(1):. PubMed ID: 27135184
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat.
Dávila-Esqueda ME; Martínez-Morales F
Exp Diabesity Res; 2004; 5(4):245-51. PubMed ID: 15763938
[TBL] [Abstract][Full Text] [Related]
20. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
